Such analysis could shed light on whether LncDARS‐AS1‐mediated regulation of ATP1A1 and NKA activity might serve as a target in other cancer types, thereby offering a potential therapeutic avenue for a wider range of malignancies. The gene discussed is TAC1; the disease is cancer.